Burcon NutraScience Corporation's stock is experiencing a notable decline, raising concerns among investors.
Burcon NutraScience Corporation (BU.TO) is having a tough trading session, with its stock dropping by 4.76% to close at CA$1.80. This decline comes despite recent developments that highlighted the company's growth.
Advertisement
Burcon NutraScience Corporation
BU.TO
BU.TO
Burcon NutraScience Corporation
WealthAwesomeAdvertisement
Market cap
$23.99M
52W high
$2.99
52W low
$1.51
1W change
+5.00%
Beta
2.94
Analyst Price Targets
Based on analyst covering BU
Wall Street analysts forecast BU stock price to fall 2.1% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.85
-2.1% Upside
Current Price
C$1.89
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BU's historical volatility
30-Day Vol
67.8%
Annualized
90-Day Vol
66.8%
Annualized
Trend (90d)
-25.9%
Annualized drift
90d Mean
C$1.72
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.83 | C$1.45 – C$2.32 |
| 60 trading days | C$1.78 | C$1.28 – C$2.47 |
| 90 trading days | C$1.72 | C$1.15 – C$2.58 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should keep an eye on Burcon's performance, especially given its recent revenue growth and rights offering, as market sentiment seems to be shifting.
Burcon's stock down 4.76% today
The market cap now stands at about CA$23.99 million, reflecting investor concerns amid recent performance fluctuations.
Bull case
Burcon has shown strong revenue growth in its latest fiscal results, suggesting a positive path for its commercial operations.
Bear case
The current decline might indicate investor doubts about the sustainability of Burcon's growth, especially in a competitive market.
Recent Performance Overview
Advertisement
Burcon NutraScience Corporation's stock has seen a significant drop today, falling 4.76%. This decline follows a recent rights offering that raised around $9.43 million, yet investor confidence seems to be wavering.
Market Sentiment and Future Outlook
Despite Burcon's reported strong revenue growth and advancements in commercial production, today’s stock slide may reflect broader market concerns. Investors should think about the implications of this performance as they assess the company's future prospects. For more details on Burcon's financials, check out their latest results.
Key Developments
Burcon has recently shifted from technology development to commercial execution, achieving new production records. However, the current stock decline suggests that investors may be cautious about the sustainability of this growth. For further insights, visit the Burcon stock page for updates.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
